Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Liu J et al. | 2024 | intact cell/cell culture, <i>Aspergillus niger</i> | magnetic field, static magnetic field, 50/60 Hz | - |
Dacha M et al. | 1993 | intact cell/cell culture, human erythrocytes | electric field, magnetic field, 50/60 Hz | 0.2 µT–0.2 mT |
Fiorani M et al. | 1992 | intact cell/cell culture, human myeloid leukemia cell line (K-562) | electric field, magnetic field, 50/60 Hz | 0.2–200 µT |
Azadniv M et al. | 1992 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | electric field, magnetic field, 50/60 Hz | 1 µT |
Caprani A et al. | 2004 | intact cell/cell culture, EA.hy926 cells (human endothelial cell line) | electric field, magnetic field, 50/60 Hz, inhouse wiring, residential | 1.8–25 µT |
House RV et al. | 2000 | animal, mouse/B6C3F1, whole body | magnetic field, 50/60 Hz | 2 µT–1 mT |
Opler M et al. | 1997 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 6.7–8 µT |
Goodman R et al. | 2009 | invertebrate, head and tail portions of planarian/<i>Dugesia dorotocethala</i> | magnetic field, low frequency, 50/60 Hz | 8–9.5 µT |
Cocek A et al. | 2012 | intact cell/cell culture, human peripheral blood T lymphocytes | magnetic field, 50/60 Hz, co-exposure | 0.01–10 mT |
Destefanis M et al. | 2015 | intact cell/cell culture, SKBR3 (human breast cancer cells), GTL16 (human gastric cancer cells), HT29 (human colon cancer cells), A375P (human melanoma cells) | magnetic field, 50/60 Hz | 12 µT |
Parkinson WC et al. | 1992 | intact cell/cell culture, diatom (<i>Amphora coffeiformis</i>) | magnetic field, low frequency, 50/60 Hz, DC, static magnetic field | 20.9–85 µT |
Ramoni C et al. | 1995 | intact cell/cell culture, human peripheral blood mononuclear cells and lymphocytes | magnetic field, 50/60 Hz | 35 µT–10 mT |
Volpe P et al. | 1998 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, 50/60 Hz | 45–70 µT |
Woods M et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 46–100 µT |
Jandova A et al. | 2005 | isolated antigens in T cell suspensions | magnetic field, 50/60 Hz, DC, static magnetic field | 0.05–0.1 mT |
Sun W et al. | 2008 | intact cell/cell culture, FL cells (human amniotic cells) | magnetic field, low frequency, 50/60 Hz | 0.05–0.4 mT |
Cocek A et al. | 2008 | intact cell/cell culture, human T-lymphocytes | magnetic field, 50/60 Hz | 0.05–0.5 mT |
Stevenson AP et al. | 1985 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | electric field, magnetic field, 50/60 Hz | 50–800 µT |
Frahm J et al. | 2006 | intact cell/cell culture, macrophages (mouse) | magnetic field, 50/60 Hz | 0.05–1 mT |
Calabro E et al. | 2013 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 0.05–1.41 mT |
Capri M et al. | 2004 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, 50/60 Hz, co-exposure | 0.05–2.5 mT |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Valtersson U et al. | 1997 | intact cell/cell culture, CEM-CM3 (human acute lymphoblastic leukemia) cells and Jurkat cells (human lymphoblastoid T cells) | magnetic field, 50/60 Hz | 100 µT |
Marron MT et al. | 1986 | slime mold, <i>Physarum polycephalum</i> | electric field, magnetic field, 50/60 Hz | 100 µT |
Dibirdik I et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.